BeOne Medicines AG Share Price
Equities
ONC
US07725L1026
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 308.74 USD | +3.95% |
|
-2.47% | +1.62% |
| 05-07 | RBC Capital Adjusts BeOne Medicines PT to $425 From $423, Maintains Outperform Rating | MT |
| 05-07 | BeOne Medicines Shares Surge After Robust First-Quarter | DJ |
| Capitalization | 34.32B 29.52B 27.02B 25.53B 47.17B 3,315B 47.93B 320B 125B 1,565B 129B 126B 5,451B | P/E ratio 2026 * |
45.9x | P/E ratio 2027 * | 32.1x |
|---|---|---|---|---|---|
| Enterprise value | 30.26B 26.02B 23.82B 22.5B 41.58B 2,922B 42.25B 282B 110B 1,380B 114B 111B 4,805B | EV / Sales 2026 * |
4.67x | EV / Sales 2027 * | 3.98x |
| Free-Float |
0.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BeOne Medicines AG
| 1 day | +3.95% | ||
| 1 week | -2.47% | ||
| Current month | +4.56% | ||
| 1 month | -2.93% | ||
| 3 months | -14.75% | ||
| 6 months | -11.61% | ||
| Current year | +1.62% |
| 1 week | 289.6 |  | 309.14 |
| 1 month | 289.54 | | 322.45 |
| Current year | 271.47 | | 372.73 |
| 1 year | 235.35 | | 385.22 |
| 3 years | 126.97 | | 385.22 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 24.53 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 57 | 27/10/2010 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 50 | 21/07/2024 |
Xiao Bin Wu
PSD | President | 64 | 31/03/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 57 | 26/01/2016 |
Michael Goller
BRD | Director/Board Member | 51 | 31/03/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 52 | 30/09/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.95% | -2.47% | +30.35% | +32.73% | 34.32B | |
| +0.97% | +5.86% | -11.99% | -13.91% | 43.7B | |
| +2.06% | +0.26% | +271.46% | +481.55% | 31.96B | |
| -0.97% | -0.51% | +18.32% | -14.01% | 28.62B | |
| -1.70% | -5.83% | +20.14% | +12.65% | 25.12B | |
| +1.41% | -0.92% | - | - | 14.99B | |
| +1.44% | +0.26% | +131.52% | +4,144.54% | 13.54B | |
| +0.93% | +5.56% | +10.86% | +3.29% | 12.71B | |
| +1.65% | -3.27% | +117.75% | +91.53% | 12.4B | |
| +0.47% | -0.45% | +37.59% | +100.05% | 12.05B | |
| Average | +1.02% | -0.57% | +69.55% | +537.60% | 22.94B | |
| Weighted average by Cap. | +1.09% | -0.48% | +65.55% | +346.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.48B 5.57B 5.1B 4.82B 8.9B 626B 9.05B 60.47B 23.66B 295B 24.31B 23.8B 1,029B | 7.43B 6.38B 5.84B 5.52B 10.2B 717B 10.37B 69.29B 27.11B 339B 27.86B 27.28B 1,179B |
| Net income | 759M 653M 597M 564M 1.04B 73.3B 1.06B 7.08B 2.77B 34.6B 2.85B 2.79B 121B | 1.09B 938M 859M 812M 1.5B 105B 1.52B 10.18B 3.98B 49.75B 4.09B 4.01B 173B |
| Net Debt | -4.07B -3.5B -3.2B -3.02B -5.59B -393B -5.68B -37.96B -14.85B -185B -15.26B -14.94B -646B | -4.76B -4.09B -3.74B -3.54B -6.54B -459B -6.64B -44.38B -17.36B -217B -17.84B -17.47B -755B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 308.74 $ | +3.95% | 291,217 |
| 19/05/26 | 297.01 $ | +1.34% | 219,132 |
| 18/05/26 | 293.09 $ | -0.06% | 217,637 |
| 15/05/26 | 293.27 $ | -3.73% | 269,815 |
| 14/05/26 | 304.62 $ | -3.77% | 261,909 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition